3667391
Last Update Posted: 2020-04-27
Recruiting status is unknown
All Genders accepted | 20 Years + |
200 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry
The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is difficult for numerous reasons and is related with a poor prognosis. In Taiwan, the incidence of CTEPH and its clinical features are unknown. This study aims at evaluating the prevalence, clinical characteristics, and management of CTEPH in a Taiwanese cohort.
Primary objective:
- To investigate the geodemographics of CTEPH in Taiwan
Secondary objectives:
- To characterize the demographics and clinical presentation of patients with CTEPH
- To describe the real-world management and treatment outcome of patients with CTEPH
- To identify the risk factors of CTEPH
- To assess the relationship between risk factors/patients' characteristics and clinical outcomes for CTEPH
- To evaluate the prognosis of CTEPH in Taiwan using survival assessment
Eligibility
Relevant conditions:
The Geodemographics of CTEPH in Taiwan
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Hsao H Hsu, PhD
ntuhsu@gmail.com
+886 972651420
Data sourced from ClinicalTrials.gov